One vindication by procurement, one falsification by Eroom’s Law, and a nanobot deadline that even Kurzweil has pushed back.
Every mechanism Kurzweil predicted for 2010s nanomedicine has now worked in a human body at least once. The clinic still looks nothing like he drew.
Seven 2005 predictions about replacement organs, therapeutic cloning, and bloodstream nanobots — graded against 2026 reality.
Kurzweil’s press-a-button cancer kill arrived — just not through the mechanism he predicted. Respirocytes and microbivores remain on paper.
Ten things Kurzweil said were already true in 2005, audited against 2026 evidence. The most-cited stat about the human body turns out to be wrong — in both directions.
Twenty-one years after Singularity Is Near, ten claims Kurzweil said were already true: what held up, what got overtaken, and the company whose path he rewrote.
The endocrine organ MicroCHIPS was supposed to ship by 2008 now rides a belt clip — while a May 2024 patent claims Kurzweil’s telomere-reset stem cells nearly word-for-word.
Kurzweil called the targets on medicine but missed the projectiles: wastewater not serum, mRNA not RNAi, senolytics not nanobots.
Twelve Kurzweil predictions about brain prosthetics, tested against the patents granted last quarter and the papers in NEJM from last October.
Kurzweil predicted diamondoid organs by the 2030s. What shipped is peptide drugs, living cells, and a titanium impeller on a magnetic field.